-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/aD-Br2oTJ67FeNdHHkLtPA
April 22, 2004 - Intense craving, stress from the lifestyle
Psychosis after repeated use of high doses
Sudden death … repeated use of high doses
Permanent damage to brain cells
Liver damage, brain haemorrhage, sudden death … reactions, hypoxia
Delirium, seizures, coma, organ damage (heart, lungs, liver, kidneys)
Death … Severe withdrawal symptoms
Overdose and death if used with alcohol, opioids or other depressant drugs … work problems, violations of law
Tolerance and dependence, withdrawal symptoms
Overdose and death
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/v1-breast-cancer-medications-for-risk-reduction--s
July 08, 2002 - archived
Final Recommendation Statement
Breast Cancer: Medications for Risk Reduction
July 08, 2002
Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Departm…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/breast-cancer-medications-for-risk-reduction-2002
July 08, 2002 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
archived
Final Recommendation Statement
Breast Cancer: Medications for Risk Reduction
July 08, 2002
Recommendations made by the USPSTF are independent of the U.S. gove…
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/We5A-uCMvX5qYeFukGgqks
March 01, 2004 - Death was definitely associated with biopsy in
2 of 1,500 patients and was possibly associated
with biopsy … cirrhosis;
0.135 [95% CI, incidence of
0.049–0.372]) hepatocellular
cancer and
Adjusted RR for death … evidence regarding
reduce the risk for or rate benefits of screening in the
of harm and premature death … death, perforation) from liver biopsy
was approximately 1%–2%, with
mortality less than 0.3%. … biopsy complications observational study complications and complications
who have major (bleeding, death
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-use-prevent-cardiovascular-disease-colorectal-cancer-preventive-medication-2002
January 01, 2002 - including ischemic coronary heart disease, stroke, and peripheral vascular disease, is the leading cause of death … Collaborative overview of randomised trials of antiplatelet therapy—I: Prevention of death, myocardial
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/lung-cancer-screening-1996
January 01, 1996 - Suffering
Cancer of the lung is the leading cause of death … produced similar results. 24 The investigators found no substantial difference in the number or causes of death
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary43/prostate-cancer-screening-2012
October 07, 2011 - Prostatectomy was associated with perioperative death (about 0.5%) and cardiovascular events (0.6% to … for an estimated 1410 men invited to screening and 48 treated to prevent 1 prostate cancer–specific death … overdiagnosis because of the detection of low-risk cancers that would not have caused morbidity or death … PSA-based screening identifies more prostate cancers, but most trials found no effect on risk for death … Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sTjqbTas6gW5pzaATpeBDn
January 01, 2013 - hormone therapy in-
creases the risk for invasive breast cancer incidence and
possibly breast cancer death … Cardiovascular Events
The primary outcome of interest in WHI was the rate
of CHD (defined as CHD death … post hoc analysis reported that the use of combined
therapy was associated with an increased risk for death
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/integrating-evidence-based-clinical-and-community-strategies-improve-health
March 12, 2021 - conducive to health increase the risk of disease and injury and contribute to the leading causes of death … Actual causes of death in the United States, 2000. JAMA 2004;291(10):1238-45. … Correction: actual causes of death in the United States, 2000. JAMA 2005;293(3):293-4.
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/drug-use-illicit-primary-care-interventions-for-children-and-adolescents
May 26, 2020 - health, social, and economic consequences and is a significant contributor to 3 of the leading causes of death … alcohol and illicit drugs are the primary health risk behaviors that contribute to these causes of death
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/ipv-abuse-bulletin.pdf
November 25, 2024 - bones, pain, anxiety, depression,
sexually transmitted infections, unintended pregnancy, and risk of death
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/osteoporosis-screening-final-rec-bulletin.pdf
January 14, 2025 - normal, healthy bone and can result in serious disability,
chronic pain, loss of independence, and even death
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/colorectal-cancer-screening-2008
October 15, 2008 - Colorectal cancer is the third most common type of cancer and the second leading cause of cancer death … for all the screening methods, with the highest risks for morbidity, hospitalization, and (rarely) death
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/child-maltreatment-interventions-final-rec-bulletin.pdf
March 19, 2024 - Maltreatment can lead to devastating effects, such as injury and death, and can also lead to long-term
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication
November 13, 2016 - For the JUPITER trial, we interpreted “MI, stroke, or cardiovascular death” as reported in the main trial … publication (2) as “myocardial death, stroke death, or cardiovascular death,” when it meant “nonfatal … myocardial infarction, nonfatal stroke, or cardiovascular death.” … adverse outcomes of CVD is that the first clinical manifestation can be catastrophic, including sudden cardiac … to prevent 1 cardiovascular death was 500 after 2 to 6 years.
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-statins/statin-use-in-adults-preventive-medication-november-2016
November 13, 2016 - For the JUPITER trial, we interpreted “MI, stroke, or cardiovascular death” as reported in the main trial … publication (2) as “myocardial death, stroke death, or cardiovascular death,” when it meant “nonfatal … myocardial infarction, nonfatal stroke, or cardiovascular death.” … adverse outcomes of CVD is that the first clinical manifestation can be catastrophic, including sudden cardiac … to prevent 1 cardiovascular death was 500 after 2 to 6 years.
-
www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-appendix-xiii-template-scoping-decision-problem-address-through-decision-modeling
July 01, 2017 - Procedure Manual Appendix XIII. Template for Scoping the “Decision Problem” to Address Through Decision Modeling
Date:
P…
-
www.uspreventiveservicestaskforce.org/uspstf/behavioral-counseling-interventions-an-evidence-based-approach---table-1
November 01, 2013 - Behavioral Counseling Interventions: An Evidence-based Approach - Table 1
Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Table 1. Healthy People 2010 Leading Health Indicators a
Health Indicator
1997 Basel…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary23/diabetes-mellitus-type-2-in-adults-screening-2008
June 15, 2008 - of an HMG-CoA reductase inhibitor in primary and secondary prevention of cardiovascular events and death … Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. … Fair
Acarbose: NSD in death from placebo; gastrointestinal side effects common. … Metformin: NSD in death, hypoglycemia, lactic acidosis vs. placebo or diet. … CHD death or nonfatal MI:
DM subgroup: 0.89 (0.71-1.10); P = NR
Non-DM: 0.92 (0.76-1.10);
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
June 01, 2008 - of an HMG-CoA re-
ductase inhibitor in primary and secondary prevention of
cardiovascular events and death … Few
data exist on the effect of these interventions on cardiovascular events,
death, or other long-term … Fair Acarbose: NSD in death from placebo; gastrointestinal side effects
common. … Metformin: NSD in death, hypoglycemia, lactic acidosis vs. placebo or
diet. … Effect of rosiglitazone on the risk of myocardial
infarction and death from cardiovascular causes.